Livingstone Shona J, Morales Daniel R, McMinn Megan, Eke Chima, Donnan Peter, Guthrie Bruce
Population Health and Genomics Division, University of Dundee, Dundee, UK.
Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
BMJ Med. 2022 Oct 25;1(1):e000316. doi: 10.1136/bmjmed-2022-000316. eCollection 2022.
To externally evaluate the QFracture risk prediction tool for predicting the risk of major osteoporotic fracture and hip fracture.
External validation cohort study.
UK primary care population. Linked general practice (Clinical Practice Research Datalink (CPRD) Gold), mortality registration (Office of National Statistics), and hospital inpatient (Hospital Episode Statistics) data, from 1 January 2004 to 31 March 2016.
2 747 409 women and 2 684 730 men, aged 30-99 years, with up-to-standard linked data that had passed CPRD checks for at least one year.
Two outcomes were modelled based on the QFracture: major osteoporotic fracture and hip fracture. Major osteoporotic fracture was defined as any hip, distal forearm, proximal humerus, or vertebral crush fracture, from general practice, hospital discharge, and mortality data. The QFracture 10 year predicted risk of major osteoporotic fracture and hip fracture was calculated, and performance evaluated versus observed 10 year risk of fracture in the whole population, and in subgroups based on age and comorbidity. QFracture calibration was examined accounting for, and not accounting for, competing risk of mortality from causes other than the major osteoporotic fracture.
2 747 409 women with 95 598 major osteoporotic fractures and 36 400 hip fractures, and 2 684 730 men with 34 321 major osteoporotic fractures and 13 379 hip fractures were included in the analysis. The incidence of all fractures was higher than in the QFracture internal derivation. Competing risk of mortality was more common than fracture from middle age onwards. QFracture discrimination in the whole population was excellent or good for major osteoporotic fracture and hip fracture (Harrell's C statistic in women 0.813 and 0.918, and 0.738 and 0.888 in men, respectively), but was poor to moderate in age subgroups (eg, Harrell's C statistic in women and men aged 85-99 years was 0.576 and 0.624 for major osteoporotic fractures, and 0.601 and 0.637 for hip fractures, respectively). Without accounting for competing risks, QFracture systematically under-predicted the risk of fracture in all models, and more so for major osteoporotic fracture than for hip fracture, and more so in older people. Accounting for competing risks, QFracture still under-predicted the risk of fracture in the whole population, but over-prediction was considerable in older age groups and in people with high comorbidities at high risk of fracture.
The QFracture risk prediction tool systematically under-predicted the risk of fracture (because of incomplete determination of fracture rates) and over-predicted the risk in older people and in those with more comorbidities (because of competing mortality). The use of QFracture in its current form needs to be reviewed, particularly in people at high risk of death from other causes.
对外评估用于预测主要骨质疏松性骨折和髋部骨折风险的QFracture风险预测工具。
外部验证队列研究。
英国基层医疗人群。关联了2004年1月1日至2016年3月31日期间的全科医疗(临床实践研究数据链(CPRD)黄金数据)、死亡率登记(国家统计局)以及医院住院患者(医院事件统计)数据。
2747409名女性和2684730名男性,年龄在30 - 99岁之间,拥有至少经过一年CPRD检查的达标关联数据。
基于QFracture对两种结局进行建模:主要骨质疏松性骨折和髋部骨折。主要骨质疏松性骨折定义为来自全科医疗、医院出院及死亡率数据中的任何髋部、远端前臂、近端肱骨或椎体压缩性骨折。计算QFracture预测的10年主要骨质疏松性骨折和髋部骨折风险,并与整个人群以及基于年龄和合并症的亚组中观察到的10年骨折风险进行对比,评估其性能。在考虑和不考虑除主要骨质疏松性骨折之外其他原因导致的死亡竞争风险的情况下,检查QFracture校准情况。
分析纳入了2747409名发生95598例主要骨质疏松性骨折和36400例髋部骨折的女性,以及2684730名发生34321例主要骨质疏松性骨折和13379例髋部骨折的男性。所有骨折的发生率高于QFracture内部推导数据。从中年起,死亡竞争风险比骨折更为常见。QFracture在整个人群中对主要骨质疏松性骨折和髋部骨折的区分度良好或优秀(女性的Harrell C统计量分别为0.813和0.918,男性分别为0.738和0.888),但在年龄亚组中为中等至较差(例如,85 - 99岁女性和男性主要骨质疏松性骨折的Harrell C统计量分别为0.576和0.624,髋部骨折分别为0.601和0.637)。在不考虑竞争风险的情况下,QFracture在所有模型中均系统性地低估了骨折风险,且主要骨质疏松性骨折比髋部骨折低估得更多,在老年人中更是如此。在考虑竞争风险的情况下,QFracture在整个人群中仍低估了骨折风险,但在老年人群体以及具有高合并症且骨折风险高的人群中存在相当程度的高估。
QFracture风险预测工具系统性地低估了骨折风险(由于骨折率确定不完整),并且高估了老年人和合并症更多人群的风险(由于死亡竞争)。需要对当前形式的QFracture的使用进行审查,尤其是在因其他原因死亡风险高的人群中。